| Safety and efficacy of a CXCR 2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo‐controlled clinical trial P Nair, M Gaga, E Zervas, K Alagha, FE Hargreave, PM O'byrne, ... Clinical & Experimental Allergy 42 (7), 1097-1103, 2012 | 360 | 2012 |
| Anti-IgE treatment, airway inflammation and remodelling in severe allergic asthma: current knowledge and future perspectives K Samitas, V Delimpoura, E Zervas, M Gaga European respiratory review 24 (138), 594-601, 2015 | 132 | 2015 |
| Exhaled cysteinyl-leukotrienes and 8-isoprostane in patients with asthma and their relation to clinical severity K Samitas, D Chorianopoulos, S Vittorakis, E Zervas, E Economidou, ... Respiratory medicine 103 (5), 750-756, 2009 | 121 | 2009 |
| Genetics and epigenetics in asthma P Ntontsi, A Photiades, E Zervas, G Xanthou, K Samitas International Journal of Molecular Sciences 22 (5), 2412, 2021 | 119 | 2021 |
| Osteopontin expression and relation to disease severity in human asthma K Samitas, E Zervas, S Vittorakis, M Semitekolou, T Alissafi, A Bossios, ... European Respiratory Journal 37 (2), 331-341, 2011 | 110 | 2011 |
| An algorithmic approach for the treatment of severe uncontrolled asthma E Zervas, K Samitas, AI Papaioannou, P Bakakos, S Loukides, M Gaga ERJ open research 4 (1), 2018 | 104 | 2018 |
| T2-low asthma: current approach to diagnosis and therapy K Samitas, E Zervas, M Gaga Current opinion in pulmonary medicine 23 (1), 48-55, 2017 | 101 | 2017 |
| ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions A Bourdin, L Bjermer, C Brightling, GG Brusselle, P Chanez, KF Chung, ... European respiratory journal 54 (3), 2019 | 88 | 2019 |
| Can steroids reverse the severe COVID‐19 induced “cytokine storm”? L Kolilekas, K Loverdos, S Giannakaki, L Vlassi, A Levounets, E Zervas, ... Journal of medical virology 92 (11), 2866-2869, 2020 | 87 | 2020 |
| Control of asthma in real life: still a valuable goal? AI Papaioannou, K Kostikas, E Zervas, L Kolilekas, S Papiris, M Gaga European Respiratory Review 24 (136), 361-369, 2015 | 79 | 2015 |
| Risk factors and characteristics associated with severe and difficult to treat asthma phenotype: an analysis of the ENFUMOSA group of patients based on the ECRHS questionnaire M Gaga, N Papageorgiou, G Yiourgioti, P Karydi, A Liapikou, H Bitsakou, ... Clinical & Experimental Allergy 35 (7), 954-959, 2005 | 76 | 2005 |
| Control of asthma under specialist care: is it achieved? M Gaga, N Papageorgiou, E Zervas, D Gioulekas, S Konstantopoulos Chest 128 (1), 78-84, 2005 | 66 | 2005 |
| Reduced intracellular Mg concentrations in patients with acute asthma E Zervas, G Papatheodorou, K Psathakis, P Panagou, N Georgatou, ... Chest 123 (1), 113-118, 2003 | 65 | 2003 |
| Clinical asthma phenotypes in the real world: opportunities and challenges C Bostantzoglou, V Delimpoura, K Samitas, E Zervas, F Kanniess, ... Breathe 11 (3), 186-193, 2015 | 62 | 2015 |
| Association of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancer G Mountzios, E Samantas, K Senghas, E Zervas, J Krisam, K Samitas, ... ESMO open 6 (5), 100254, 2021 | 43 | 2021 |
| Evaluation and management of severe asthma M Gaga, E Zervas, S Grivas, M Castro, P Chanez Current medicinal chemistry 14 (9), 1049-1059, 2007 | 40 | 2007 |
| Inhaled corticosteroids in COPD: pros and cons E Zervas, K Samitas, M Gaga, B Beghe, L M Fabbri Current Drug Targets 14 (2), 192-224, 2013 | 39 | 2013 |
| Differences in microsatellite DNA level between asthma and chronic obstructive pulmonary disease MI Zervou, EG Tzortzaki, D Makris, M Gaga, E Zervas, E Economidou, ... European Respiratory Journal 28 (3), 472-478, 2006 | 39 | 2006 |
| Update on severe asthma: what we know and what we need M Gaga, E Zervas, P Chanez European Respiratory Review 18 (112), 58-65, 2009 | 38 | 2009 |
| Activin-A is overexpressed in severe asthma and is implicated in angiogenic processes K Samitas, N Poulos, M Semitekolou, I Morianos, S Tousa, E Economidou, ... European Respiratory Journal 47 (3), 769-782, 2016 | 37 | 2016 |
